Drugs Online » Prescription Drugs 14 » Senzia Avandia
Rosiglitazone is an anti-diabetic drug (thiazolidinedione-type also called "glitazones") used with a proper diet and exercise program to control high blood sugar in patients with type 2 diabetes (non-insulin-dependent diabetes). Rosiglitazone works by helping to restore your body's proper response to insulin thereby lowering your blood sugar. Controlling high blood sugar helps prevent kidney damage blindness nerve problems loss of limbs and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke.
Buy Senzia Avandia and other Prescription Drugs 14 products online
at Medstore.
Buy Online at Medstore - Click Here!

About Senzia Avandia:
Product Type: Prescription Drugs 14
Senzia ( Avandia Generic Rosiglitazone )
Senzia (Avandia Generic Rosiglitazone)
Avandia Generic Rosiglitazone
8mg
Avandia Generic Rosiglitazone Senzia

View more
Prescription Drugs 14
Previous Product Next Product
Drugs Online:
From Gulf News: Runners should avoid prescription drugs. Statins may increase production of the enzyme creatine kinase, and hence heighten chances of muscle damage in athletes. Marathon running has increased in popularity over the past three decades, with participation in the United States rising from 25,000 runners in 1976 to nearly 470,000 in 2008. Many professional and recreational runners take prescription drugs, unaware of potential side-effects that affect runners in particular. One such class of drugs, called statins, which includes medicines such as Lipitor, Crestor and Pravachol, lowers blood cholesterol by inhibiting a cholesterol-producing enzyme and may even lower the risks of heart attack and further cardiovascular disease in a narrow category of patients. A new study forthcoming in the American Journal of Cardiology examined the effect of statins on creatine kinase (CK), an enzyme linked to muscle damage. Elevated levels of CK in the blood and muscle after exercise correlates with muscle damage. The study, conducted by Dr Beth Parker of the Henry Low Heart Centre at Connecticut's Hartford Hospital, is the first to measure CK levels in athletes taking statins after physical activity in a real-life environment rather than in a university laboratory.


|